{
"id":"mk19_bb_np_s16",
"subspecialtyId":"np",
"title":"Glomerular Diseases",
"jsonContent":{
"type":"section",
"id":"mk19_bb_np_s16",
"title":{
"__html":"Glomerular Diseases"
},
"titleNode":{
"type":"section-title",
"hlId":"a1bfb2",
"children":[
"Glomerular Diseases"
]
},
"children":[
{
"type":"section",
"id":"mk19_bb_np_s16_0",
"children":[
{
"type":"p",
"hlId":"65c734",
"children":[
"Glomerular disease should be suspected when proteinuria and/or hematuria are seen on urinalysis."
]
},
{
"type":"p",
"hlId":"06586c",
"children":[
"The most common distinction is usually made between the nephrotic syndromes and the nephritic syndromes, also referred to as ",
{
"type":"no-wrap",
"children":[
{
"type":"abbreviation",
"title":"glomerulonephritis",
"children":[
"GN"
]
},
"."
]
},
" Some conditions may present with either or both patterns, and some may progress from one pattern to the other."
]
}
]
},
{
"type":"section",
"id":"mk19_bb_np_s16_1",
"title":{
"__html":"The Nephrotic Syndrome"
},
"titleNode":{
"type":"section-title",
"hlId":"6ffb55",
"children":[
"The Nephrotic Syndrome"
]
},
"children":[
{
"type":"p",
"hlId":"daf10f",
"children":[
" ",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Diagnosis"
]
},
" "
]
},
{
"type":"p",
"hlId":"3135b4",
"children":[
"The nephrotic syndrome is characterized by:"
]
},
{
"type":"list",
"children":[
" ",
{
"type":"list-item",
"hlId":"1346f6",
"children":[
"urine protein excretion >3500 mg/24 h or a urine protein-creatinine ratio >3500 mg/g"
]
},
" ",
{
"type":"list-item",
"hlId":"672314",
"children":[
"hypoalbuminemia, edema, and hyperlipidemia may be present"
]
},
" "
]
},
{
"type":"p",
"hlId":"068f7c",
"children":[
"The nephrotic syndrome may be primary or secondary to systemic diseases such as diabetes, infection, or autoimmune diseases."
]
},
{
"type":"inline-wrap",
"wrapId":"1",
"contentIds":[
"mk19_bb_np_s16_inline_t1"
],
"forceOpen":true
},
{
"type":"heading",
"class":"tricked",
"children":[
"Don't Be Tricked"
]
},
{
"type":"list",
"class":"tricked",
"children":[
" ",
{
"type":"list-item",
"hlId":"7df247",
"children":[
"Nephrotic range proteinuria in a patient with diabetes but without microvascular (e.g., retinopathy) or macrovascular (e.g., ",
{
"type":"abbreviation",
"title":"coronary artery disease",
"children":[
"CAD"
]
},
") disease is not caused by diabetes. Kidney biopsy is required for definitive diagnosis."
]
},
" "
]
},
{
"type":"p",
"hlId":"afcd3e",
"children":[
" ",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Treatment"
]
},
" "
]
},
{
"type":"p",
"hlId":"08691a",
"children":[
"Treatment of the consequences of the nephrotic syndrome should occur simultaneously with treatment of the specific cause (if nephrotic syndrome is secondary to an underlying condition):"
]
},
{
"type":"list",
"children":[
" ",
{
"type":"list-item",
"hlId":"17f343",
"children":[
"statins for elevated lipid levels"
]
},
" ",
{
"type":"list-item",
"hlId":"4d253d",
"children":[
"anticoagulation for thrombotic complications (because of urinary loss of antithrombins)"
]
},
" ",
{
"type":"list-item",
"hlId":"f3cf16",
"children":[
"low-salt diet and loop diuretics for edema"
]
},
" "
]
},
{
"type":"inline-wrap",
"wrapId":"3",
"contentIds":[
"mk19_bb_np_f04"
],
"forceOpen":true
}
]
},
{
"type":"section",
"id":"mk19_bb_np_s16_2",
"title":{
"__html":"The Nephritic Syndrome"
},
"titleNode":{
"type":"section-title",
"hlId":"52342b",
"children":[
"The Nephritic Syndrome"
]
},
"children":[
{
"type":"p",
"hlId":"daf10f",
"children":[
" ",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Diagnosis"
]
},
" "
]
},
{
"type":"p",
"hlId":"178bc2",
"children":[
"The nephritic syndrome (glomerulonephritis) is associated with glomerular inflammation resulting in hematuria, proteinuria, and leukocytes in the urine sediment. The hallmark is the presence of dysmorphic erythrocytes and erythrocyte casts. Proteinuria is variable. Systemic findings may include edema, hypertension, and kidney failure."
]
},
{
"type":"inline-wrap",
"wrapId":"4",
"contentIds":[
"mk19_bb_np_f05"
],
"forceOpen":true
},
{
"type":"inline-wrap",
"wrapId":"5",
"contentIds":[
"mk19_bb_np_f06"
],
"forceOpen":true
},
{
"type":"heading",
"class":"tricked",
"children":[
"Don't Be Tricked"
]
},
{
"type":"list",
"class":"tricked",
"children":[
" ",
{
"type":"list-item",
"hlId":"c93dd5",
"children":[
"The absence of erythrocyte casts does not rule out glomerulonephritis."
]
},
" "
]
},
{
"type":"inline-wrap",
"wrapId":"2",
"contentIds":[
"mk19_bb_np_s16_inline_t2",
"mk19_bb_np_s16_inline_t3"
],
"forceOpen":true
},
{
"type":"p",
"hlId":"f5172e",
"children":[
"Rapidly progressive GN is a clinical syndrome characterized by evidence of GN with progression to kidney failure within weeks. Findings include oliguria, rising serum creatinine levels, macroscopic or microscopic hematuria, erythrocyte casts, and proteinuria. It may be associated with any cause of GN or may be idiopathic. Rapidly progressive GN is particularly common with anti-",
{
"type":"abbreviation",
"title":"glomerular basement membrane",
"children":[
"GBM"
]
},
" antibody disease (in younger patients) and pauci-immune small-vessel vasculitis (in older patients). Serologic testing (e.g., ",
{
"type":"no-wrap",
"children":[
{
"type":"abbreviation",
"title":"antineutrophil cytoplasmic antibody",
"children":[
"ANCA"
]
},
","
]
},
" anti-GBM antibodies, antinuclear antibodies) aids in the diagnosis. Diagnosis is made by kidney biopsy."
]
}
]
},
{
"type":"section",
"id":"mk19_bb_np_s16_3",
"title":{
"__html":"Anti–Glomerular Basement Membrane Antibody Disease"
},
"titleNode":{
"type":"section-title",
"hlId":"2a8881",
"children":[
"Anti–Glomerular Basement Membrane Antibody Disease"
]
},
"children":[
{
"type":"p",
"hlId":"5c7b63",
"children":[
"Anti-GBM disease is an autoimmune disorder caused by antibodies directed against type IV collagen. If pulmonary capillaries are involved, it causes pulmonary hemorrhage (Goodpasture syndrome). Anti-GBM disease presents as ",
{
"type":"abbreviation",
"title":"rapidly progressive glomerulonephritis",
"children":[
"RPGN"
]
},
" with lung involvement in >50% of patients."
]
},
{
"type":"p",
"hlId":"414cdc",
"children":[
"Findings include normal complement levels and elevated levels of anti-GBM antibodies. Kidney biopsy shows proliferative GN with linear deposition of immunoglobulin."
]
},
{
"type":"p",
"hlId":"1c1a3c",
"children":[
"Treatment is cyclophosphamide and glucocorticoids, combined with plasmapheresis."
]
}
]
},
{
"type":"section",
"id":"mk19_bb_np_s16_4",
"title":{
"__html":"ANCA-Associated Glomerulonephritis"
},
"titleNode":{
"type":"section-title",
"hlId":"5ea8d9",
"children":[
"ANCA-Associated Glomerulonephritis"
]
},
"children":[
{
"type":"p",
"hlId":"f4e4dc",
"children":[
"Kidney manifestations range from only hematuria to RPGN. Systemic symptoms may include arthritis, leukocytoclastic vasculitis (palpable purpura), and pulmonary disease (pulmonary infiltrate to pulmonary hemorrhage)."
]
},
{
"type":"p",
"hlId":"841029",
"children":[
"More than 80% of patients with ",
{
"type":"abbreviation",
"title":"microscopic polyangiitis",
"children":[
"MPA"
]
},
" or granulomatosis with polyangiitis are ANCA positive; granulomatosis with polyangiitis is associated with ",
{
"type":"no-wrap",
"children":[
"(",
{
"type":"abbreviation",
"title":"proteinase 3",
"children":[
"PR3"
]
},
")-ANCA,"
]
},
" and MPA is associated with ",
{
"type":"no-wrap",
"children":[
"(",
{
"type":"abbreviation",
"title":"myeloperoxidase",
"children":[
"MPO"
]
},
")-ANCA."
]
}
]
},
{
"type":"p",
"hlId":"868eae",
"children":[
"Complement levels are normal. Kidney biopsy shows absent or minimal staining with immunoglobulin."
]
},
{
"type":"p",
"hlId":"adc3cc",
"children":[
"Induction therapy consists of glucocorticoids and cyclophosphamide (or rituximab) with plasmapheresis if alveolar damage is evident."
]
}
]
},
{
"type":"section",
"id":"mk19_bb_np_s16_5",
"title":{
"__html":"IgA Nephropathy"
},
"titleNode":{
"type":"section-title",
"hlId":"e64c6a",
"children":[
"IgA Nephropathy"
]
},
"children":[
{
"type":"p",
"hlId":"a7e039",
"children":[
"IgA nephropathy most commonly presents as asymptomatic microscopic hematuria (with or without proteinuria) or episodic gross hematuria coincident with a ",
{
"type":"abbreviation",
"title":"upper respiratory infection",
"children":[
"URI"
]
},
" (synpharyngitic nephritis). IgA nephropathy may also present as an acute GN or RPGN, with variable degrees of ",
{
"type":"no-wrap",
"children":[
{
"type":"abbreviation",
"title":"acute kidney injury",
"children":[
"AKI"
]
},
","
]
},
" hypertension, edema, proteinuria, and hematuria."
]
},
{
"type":"p",
"hlId":"cb8294",
"children":[
"Kidney biopsy shows glomerular IgA deposits on immunofluorescence. Complement levels are normal."
]
},
{
"type":"p",
"hlId":"f5e817",
"children":[
"Most patients have a benign course without treatment; patients with proteinuria and risk factors for progression may benefit from ",
{
"type":"abbreviation",
"title":"angiotensin-converting enzyme",
"children":[
"ACE"
]
},
" inhibitors or ",
{
"type":"no-wrap",
"children":[
{
"type":"abbreviation",
"title":"angiotensin receptor blocker",
"children":[
"ARB"
]
},
"s."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_bb_np_s16_6",
"title":{
"__html":"IgA Vasculitis (Henoch-Schönlein Purpura)"
},
"titleNode":{
"type":"section-title",
"hlId":"3e9b31",
"children":[
"IgA Vasculitis (Henoch-Schönlein Purpura)"
]
},
"children":[
{
"type":"p",
"hlId":"885f50",
"children":[
"IgA vasculitis may present with the classic tetrad of rash, arthralgia, abdominal pain, and kidney disease. Kidney involvement is similar to IgA nephropathy, and other organ involvement may occur."
]
},
{
"type":"p",
"hlId":"787f55",
"children":[
"Diagnosis is confirmed either by finding an IgA-dominant leukocytoclastic vasculitis or by kidney biopsy, which shows lesions similar to IgA nephropathy. Complement levels are normal."
]
},
{
"type":"p",
"hlId":"584038",
"children":[
"Treatment of kidney disease includes glucocorticoids and, in cases of associated RPGN, cyclophosphamide."
]
}
]
},
{
"type":"section",
"id":"mk19_bb_np_s16_7",
"title":{
"__html":"Lupus Nephritis"
},
"titleNode":{
"type":"section-title",
"hlId":"759c47",
"children":[
"Lupus Nephritis"
]
},
"children":[
{
"type":"p",
"hlId":"a3fb51",
"children":[
"Patients typically have extrarenal symptoms of ",
{
"type":"abbreviation",
"title":"systemic lupus erythematosus",
"children":[
"SLE"
]
},
" at the time of diagnosis of ",
{
"type":"no-wrap",
"children":[
{
"type":"abbreviation",
"title":"lupus nephritis",
"children":[
"LN"
]
},
"."
]
}
]
},
{
"type":"p",
"hlId":"33a9e8",
"children":[
{
"type":"abbreviation",
"title":"antinuclear antibody",
"children":[
"ANA"
]
},
" and anti–double-stranded antibodies are positive, and C3 and C4 complement levels are depressed."
]
},
{
"type":"p",
"hlId":"f57ad5",
"children":[
"Classification and recommended treatment of LN is made after kidney biopsy:"
]
},
{
"type":"list",
"children":[
" ",
{
"type":"list-item",
"hlId":"818769",
"children":[
"Class I and II (minimal or proliferative mesangial) lesions require no specific therapy other than ",
{
"type":"abbreviation",
"title":"renin-angiotensin blockade",
"children":[
"RAS"
]
},
" blockade."
]
},
" ",
{
"type":"list-item",
"hlId":"093af7",
"children":[
"Class III and IV (focal and diffuse glomerular lesions) induction therapy consists of high-dose glucocorticoids and either IV cyclophosphamide or mycophenolate mofetil (less toxic)."
]
},
" ",
{
"type":"list-item",
"hlId":"85afab",
"children":[
"Class V (membranous) LN has a course similar to idiopathic membranous nephropathy, and induction therapy consists of glucocorticoids and IV cyclophosphamide, cyclosporine or tacrolimus, or mycophenolate mofetil (less toxic)."
]
},
" "
]
}
]
},
{
"type":"section",
"id":"mk19_bb_np_s16_8",
"title":{
"__html":"Infection-Related Glomerulonephritis"
},
"titleNode":{
"type":"section-title",
"hlId":"c9daaa",
"children":[
"Infection-Related Glomerulonephritis"
]
},
"children":[
{
"type":"p",
"hlId":"5db5a8",
"children":[
"Staphylococcal infection is as common as or more common than streptococcal infection as a cause of infection-related GN. The clinical manifestations of poststreptococcal GN typically occur after a latent period of 1 to 6 weeks (check antistreptolysin O, anti-DNase titers) but may occur at the time of infection with other infectious agents. The presentation of infection-related GN ranges from asymptomatic microscopic hematuria to RPGN."
]
},
{
"type":"p",
"hlId":"060354",
"children":[
"Diagnosis is clinical in nephritic patients who have an ongoing or preceding infection. Complement levels are low."
]
},
{
"type":"p",
"hlId":"098d82",
"children":[
"Treatment focuses on the underlying infection."
]
}
]
},
{
"type":"section",
"id":"mk19_bb_np_s16_9",
"title":{
"__html":"Membranoproliferative Glomerulonephritis"
},
"titleNode":{
"type":"section-title",
"hlId":"51f754",
"children":[
"Membranoproliferative Glomerulonephritis"
]
},
"children":[
{
"type":"p",
"hlId":"26e04f",
"children":[
{
"type":"abbreviation",
"title":"membranoproliferative glomerulonephritis",
"children":[
"MPGN"
]
},
" manifests in children or young adults as proteinuria or the nephrotic syndrome. Two forms exist: an immune-complex form mediated by antigen-antibody interactions triggering the classic complement pathway and a complement-mediated form caused by a hyperactive alternative complement pathway. It is associated with immune complex disease (SLE), infections (",
{
"type":"abbreviation",
"title":"hepatitis C virus",
"children":[
"HCV"
]
},
"), and monoclonal gammopathy."
]
},
{
"type":"p",
"hlId":"ee8d96",
"children":[
"Complement levels are low. Diagnosis and distinction of the two types are made by kidney biopsy and immunofluorescence microscopy."
]
},
{
"type":"p",
"hlId":"60f9b7",
"children":[
"Treatment of MPGN includes immunosuppression and treatment of any underlying cause."
]
}
]
}
]
},
"tablesContent":{
"mk19_bb_np_s16_inline_t1":{
"id":"mk19_bb_np_s16_inline_t1",
"number":1,
"bookId":"np",
"title":{
"__html":"Study Table: Common Causes of the Nephrotic Syndrome"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"14b987",
"children":[
"Study Table: Common Causes of the Nephrotic Syndrome"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9e2941",
"class":"col hd l",
"children":[
"Condition"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"46cce4",
"class":"col hd l",
"children":[
"Clinical Associations"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"523223",
"class":"col hd l",
"children":[
"Diagnosis"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"4c4ac0",
"class":"col hd l",
"children":[
"Treatment"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"18a5c0",
"class":"cell txt l",
"children":[
"Focal segmental glomerulosclerosis"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"14d7a3",
"class":"cell txt l",
"children":[
"“Collapsing” variety associated with HIV"
]
},
" ",
{
"type":"p",
"hlId":"385073",
"class":"cell txt l",
"children":[
"Associated with morbid obesity"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d8a0b9",
"class":"cell txt l",
"children":[
"Biopsy"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b9c951",
"class":"cell txt l",
"children":[
"Glucocorticoids or calcineurin inhibitors"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3bc80f",
"class":"cell txt l",
"children":[
"Membranous nephropathy"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c3abc4",
"class":"cell txt l",
"children":[
" ",
{
"type":"alert",
"children":[
"Positive antibody against phospholipase A2 receptor"
]
},
" "
]
},
" ",
{
"type":"p",
"hlId":"c35ef6",
"class":"cell txt l",
"children":[
"Secondary causes include infection (hepatitis B and C, malaria, syphilis), ",
{
"type":"no-wrap",
"children":[
{
"type":"abbreviation",
"title":"systemic lupus erythematosus",
"children":[
"SLE"
]
},
","
]
},
" drugs (",
{
"type":"abbreviation",
"title":"nonsteroidal anti-inflammatory drugs",
"children":[
"NSAIDs"
]
},
"), cancer (solid tumors, lymphoma)"
]
},
" ",
{
"type":"p",
"hlId":"e33202",
"class":"cell txt l",
"children":[
"High propensity for thrombosis, especially renal vein thrombosis"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d8a0b9",
"class":"cell txt l",
"children":[
"Biopsy"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"44549f",
"class":"cell txt l",
"children":[
"30% spontaneously remit in 12-24 mo. Treat with ",
{
"type":"abbreviation",
"title":"renin-angiotensin blockade",
"children":[
"RAS"
]
},
" blockade, statins, and diuretics"
]
},
" ",
{
"type":"p",
"hlId":"53a276",
"class":"cell txt l",
"children":[
"If persistent: glucocorticoids and cyclophosphamide, calcineurin inhibitors, or rituximab"
]
},
" ",
{
"type":"p",
"hlId":"193476",
"class":"cell txt l",
"children":[
"Treat concurrent conditions in secondary membranous nephropathy"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"25d15e",
"class":"cell txt l",
"children":[
"Minimal change glomerulopathy"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c23c71",
"class":"cell txt l",
"children":[
"Most common cause of primary nephrotic syndrome in children"
]
},
" ",
{
"type":"p",
"hlId":"165cde",
"class":"cell txt l",
"children":[
"10% of nephrotic syndrome in adults"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d8a0b9",
"class":"cell txt l",
"children":[
"Biopsy"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"4b4e09",
"class":"cell txt l",
"children":[
"Initial treatment consists of glucocorticoids"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"5500d8",
"class":"cell txt l",
"children":[
"Diabetic kidney disease"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"eed0a9",
"class":"cell txt l",
"children":[
"Most common secondary cause of the nephrotic syndrome and the most common overall cause in adults"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c536f4",
"class":"cell txt l",
"children":[
"Clinical diagnosis (diabetes of long duration, albuminuria, and evidence of other microvascular and/or macrovascular disease)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"638f47",
"class":"cell txt l",
"children":[
"Excellent ",
{
"type":"abbreviation",
"title":"blood pressure",
"children":[
"BP"
]
},
" and glucose control"
]
},
" ",
{
"type":"p",
"hlId":"5c6add",
"class":"cell txt l",
"children":[
"ACE inhibitors or ARBs"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[

]
},
"mk19_bb_np_s16_inline_t2":{
"id":"mk19_bb_np_s16_inline_t2",
"number":2,
"bookId":"np",
"title":{
"__html":"Study Table: Categorization of Glomerulonephritis Based on Immunofluorescence Microscopy Findings"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"454d5a",
"children":[
"Study Table: Categorization of Glomerulonephritis Based on Immunofluorescence Microscopy Findings"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"3"
},
"children":[
" ",
{
"type":"p",
"hlId":"77fb81",
"class":"col hd c",
"children":[
" ",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Immunofluorescence Staining Pattern"
]
},
" "
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f4b597",
"class":"col hd l",
"children":[
"Granular"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"76228c",
"class":"col hd l",
"children":[
"Pauci-immune"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"32a843",
"class":"col hd l",
"children":[
"Linear"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"380873",
"class":"cell txt l",
"children":[
"Lupus nephritis"
]
},
" ",
{
"type":"p",
"hlId":"e4d540",
"class":"cell txt l",
"children":[
"Infection-related GN"
]
},
" ",
{
"type":"p",
"hlId":"2e06bf",
"class":"cell txt l",
"children":[
"IgA nephropathy"
]
},
" ",
{
"type":"p",
"hlId":"1e0f8c",
"class":"cell txt l",
"children":[
" ",
{
"type":"abbreviation",
"title":"membranoproliferative glomerulonephritis",
"children":[
"MPGN"
]
},
" "
]
},
" ",
{
"type":"p",
"hlId":"010e95",
"class":"cell txt l",
"children":[
"Cryoglobulinemic GN"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"eb444c",
"class":"cell txt l",
"children":[
"ANCA-associated GN"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"32da8c",
"class":"cell txt l",
"children":[
"Anti-GBM antibody disease"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[

]
},
"mk19_bb_np_s16_inline_t3":{
"id":"mk19_bb_np_s16_inline_t3",
"number":3,
"bookId":"np",
"title":{
"__html":"Study Table: Categorization of Glomerulonephritis Based on Serum Complement Levels"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"554336",
"children":[
"Study Table: Categorization of Glomerulonephritis Based on Serum Complement Levels"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"03774d",
"class":"col hd l",
"children":[
"Low Serum C3 and/or C4 Levels"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0d970a",
"class":"col hd l",
"children":[
"Normal Serum C3 and C4 Levels"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"380873",
"class":"cell txt l",
"children":[
"Lupus nephritis"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2e06bf",
"class":"cell txt l",
"children":[
"IgA nephropathy"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e4d540",
"class":"cell txt l",
"children":[
"Infection-related GN"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"eb444c",
"class":"cell txt l",
"children":[
"ANCA-associated GN"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f129a8",
"class":"cell txt l",
"children":[
"MPGN"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"32da8c",
"class":"cell txt l",
"children":[
"Anti-GBM antibody disease"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"010e95",
"class":"cell txt l",
"children":[
"Cryoglobulinemic GN"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d41d8c",
"class":"cell txt l",
"children":[

]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[

]
}
}
}